More details
17.04.07

2007 1st quarter sales up 20%

 

(€ millions)

2007

% of sales

2006

% of sales

07/ 06
% Change

Southern Europe(1)

33,32

78,3

27,57

77,5

21

Other EU countries

8,07

19,0

6,80

19,1

19

Other markets

1,17

2,7

1,22

3,4

(4)

SLIT

34,63

81,4

27,66

77,7

25

SCIT

6,17

14,5

6,27

17,6

(2)

Other products

1,75

4,1

1,66

4,7

5

Total Q1 sales 

42,55

100,0

35,59

100,0

20

(1) Portugal, Spain, France, Italy, Greece

2007 first quarter sales had further significant growth of over 20% on all European markets. Other markets were temporarily impacted by delays in deliveries.

The strong growth of new treatments before and during the season contributed to the very rapid increase in desensitization via the sublingual route (SLIT + 25%), the subcutaneous route (SCIT) decreased by 2%, remaining stable overall.

This good start of the year enables us to confirm our growth guidance for 2007.